More about Alkyl Amines Chemicals Limited
Fundamentals for Alkyl Amines Chemicals Limited
Regulatory Filings for Alkyl Amines Chemicals Limited
From Cost Center to Strategic Core: The Top 10 Trends Transforming Finance in 2026
CFOs Seize the Tech Purse Strings: How 2026 Budgets Are Fueling the AI Transformation
From Agentic AI to Tokenized Assets: The Fintech Trends Reshaping Financial Services
Forex Focus: How a Weakening Indian Rupee Could Reshape Markets in Q1 2026
Fundamentals for Alkyl Amines Chemicals Limited
Business Operations:
Sector: Basic MaterialsIndustry: Specialty Chemicals
Alkyl Amines Chemicals Limited manufactures and supplies amines, amine derivatives, and other specialty chemicals in India and internationally. The company offers aliphatic amine products, such as methylamines, ethylamines, isopropylamines, n-propylamines, n-butylamines, ethylhexylamines, furfurylamines, and cyclohexylamines; and amine derivatives, including dimethylamine hydrochloride, diethylamine hydrochloride, triethylamine hydrochloride, 3-ethoxy propylamine, 3-(methylaminopropyl) amine, dimethylaminopropylamine, 3-(2-ethylhexyloxy) propylamine, n-methylbenzylamine, diisopropyl ethylamine, diethylhydroxylamine, diethyl toluamide, and diethylphenyl acetamide. It also provides specialty chemicals, such as acetonitrile; 1,8-diazabicyclo[5.4.0]undec-7-ene; diethylketone/3-pentanone; alchan 100; alchan 300; 2-aminoethoxy ethanol; 2-ethoxy ethylamine; dimethylpropyleneurea; tetramethyl ethylenediamine; monomethylamine; and tempo, free radical. The company serves pharmaceutical, agrochemical, water treatment, rubber chemical, and other industries. Alkyl Amines Chemicals Limited was incorporated in 1979 and is headquartered in Navi Mumbai, India.
Revenue projections:
ALKYLAMINE is projected to see a decline in revenue compared to last year, which could lead to investor caution. A drop in earnings is often viewed as a negative signal for profitability, making it more difficult for the company to maintain investor confidence in its financial health.
Financial Ratios:
| currentRatio | 0.000000 |
|---|---|
| forwardPE | 31.705927 |
| debtToEquity | 0.000000 |
| earningsGrowth | -0.035000 |
| revenueGrowth | -0.046000 |
| grossMargins | 0.454280 |
| operatingMargins | 0.139750 |
| trailingEps | 35.340000 |
| forwardEps | 47.833330 |
Alkyl Amines Chemicals Limited's low earnings and revenue growth point to a likely decrease in profits. This suggests that the company is facing financial difficulties and may struggle to maintain its current level of profitability.
ALKYLAMINE's negative gross and operating margins indicate the company is operating at a loss, unable to generate profit from its core business activities. This suggests financial strain and potential challenges in maintaining profitability.
ALKYLAMINE's forward EPS surpassing its trailing EPS signals that the company is anticipated to be more profitable this year than last. This growth expectation highlights ALKYLAMINE's potential for increased earnings and a stronger financial performance in the upcoming year.
Price projections:
The current price of Alkyl Amines Chemicals Limited, when assessed against projections, reveals no significant risks or opportunities. This situation indicates a steady market environment, prompting investors to remain patient until more clarity emerges regarding the stock's potential.
Insider Transactions:
6 sell transactions of Alkyl Amines Chemicals Limited were recorded, with market price hovering near 1811.2333374023438.7 buy transactions of ALKYLAMINE stock were completed, with market price at 1701.0499965122767.There is no clear trend from the insider transactions, providing limited insights into whether these actions reflect growth or decline.
Recommendation changes over time:
Analysts have recently shown a sell bias for ALKYLAMINE, signaling a need for caution. Investors should not rely solely on this sentiment but instead consider a variety of market indicators to make more informed decisions about the stock's future prospects and potential risks.
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
If you have enjoyed reading, spread the word:
Good prospects:
Companies with the best and the worst fundamentals.
Latest Regulatory Filings for NSE500
Companies with the best and the worst technicals.
Understanding Divergent House Price Movements Worldwide
The 2026 Tariff Tipping Point: When Trade Policy Reaches the Consumer
From Caracas to Commodities: The Market Impact of U.S.–China Friction